CSIMarket
 


Zogenix Inc   (ZGNX)
Other Ticker:  
 
 

ZGNX's Revenue Growth by Quarter and Year

Zogenix Inc 's Revenue results by quarter and year




ZGNX Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December 26.61 2.86 3.01 2.13
III Quarter September 22.61 1.03 4.05 1.03
II Quarter June 18.79 1.09 3.16 0.83
I Quarter March 13.68 -6.57 3.18 0.00
FY   81.69 -1.59 13.40 3.99



ZGNX Revenue fourth quarter 2021 Y/Y Growth Comment
Zogenix Inc reported Revenue surge of 830.31% year on year in the fourth quarter 2021, to $ 26.61 millions, this is lower than Zogenix Inc 's recent average Revenue surge of 5.585519069102E+15%.

Looking into fourth quarter 2021 results within Major Pharmaceutical Preparations industry 18 other companies have achieved higher Revenue growth. While Zogenix Inc ' s Revenue doubling of 830.31% ranks overall at the positon no. 91 in the fourth quarter 2021.




ZGNX Revenue ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December 830.31 % -4.98 % 41.31 % -
III Quarter September 2095.15 % -74.57 % 293.2 % -85.55 %
II Quarter June 1623.85 % -65.51 % 280.72 % -69.26 %
I Quarter March - - - -
FY   - - 235.84 % -80.84 %

Financial Statements
Zogenix Inc 's fourth quarter 2021 Revenue $ 26.61 millions ZGNX's Income Statement
Zogenix Inc 's fourth quarter 2020 Revenue $ 2.86 millions Quarterly ZGNX's Income Statement
New: More ZGNX's historic Revenue Growth >>


ZGNX Revenue (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December 17.68 % 177.67 % -25.68 % 106.8 %
III Quarter September 20.33 % -5.5 % 28.16 % 24.1 %
II Quarter June 37.35 % - -0.63 % -
I Quarter March 378.32 % - 49.3 % -
FY (Year on Year)   - - 235.84 % -80.84 %




Revenue fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #19
Healthcare Sector #32
Overall #91

Revenue Y/Y Growth Statistics
High Average Low
1.0E+17 % 5.585519069102E+15 % -100 %
  (Dec 31 2017)
Revenue fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #19
Healthcare Sector #32
Overall #91
Revenue Y/Y Growth Statistics
High Average Low
1.0E+17 % 5.585519069102E+15 % -100 %
  (Dec 31 2017)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Zogenix Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
4.6893731119994E+16 % 1.3792273858822E+15 % -100 %
(Mar 31 2018)  


ZGNX's IV. Quarter Q/Q Revenue Comment
Zogenix Inc achieved in the IV. Quarter 2021 below company average Revenue jump of 17.68% quarter on quarter, to $ 26.61 millions.

Within Major Pharmaceutical Preparations industry 77 other companies have achieved higher Revenue quarter on quarter growth. While Zogenix Inc 's Revenue growth quarter on quarter, overall rank is 875.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #78
Healthcare Sector #182
Overall #875
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #78
Healthcare Sector #182
Overall #875
Revenue Q/Q Growth Statistics
High Average Low
4.6893731119994E+16 % 1.3792273858822E+15 % -100 %
(Mar 31 2018)  


ZGNX's IV. Quarter Q/Q Revenue Comment
Zogenix Inc achieved in the IV. Quarter 2021 below company average Revenue jump of 17.68% quarter on quarter, to $ 26.61 millions.

Within Major Pharmaceutical Preparations industry 77 other companies have achieved higher Revenue quarter on quarter growth. While Zogenix Inc 's Revenue growth quarter on quarter, overall rank is 875.


Zogenix Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Sep 30 2020)
Cumulative Revenue 12 Months Ending $ 81.69 $ 57.94 $ 36.37 $ 18.66 $ -1.59
Y / Y Revenue Growth (TTM) - - 2201.58 % 411.62 % -
Year on Year Revenue Growth Overall Ranking # 109 # 0 # 25 # 30 # 161
Seqeuential Revenue Change (TTM) 40.98 % 59.34 % 94.84 % - -
Seq. Revenue Growth (TTM) Overall Ranking # 391 # 52 # 33 # 67 # 0




Cumulative Revenue growth Comment
Zogenix Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 830.31% year on year, to $ 82 millions if the fiscal year would have ended in Dec 31 2021.
Zogenix Inc 's trailing twelve months Revenue growth was higher than company's average 108.63% and higher than % growth in Sep 30 2021.
But sequential increase was beneth at 40.98 % from $57.94 millions recorded in the period from Sep 30 2021 to Sep 30 2020.
There is stagnation developing, more evident as we look at average Q/Q TTM historic rise what is better at108.63%. In the Dec 31 2021 period, Zogenix Inc had cumulative twelve months Revenue of $ 82 millions compare to of $ -2 millions a year ago.
It is revival, but modest, reporting beneth average 40.98 % Revenue increase, from $57.94 millions from the twelve months ending in the quarter Sep 30 2021 Jacob  Taylor said.

In the Healthcare sector 37 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 109.

Revenue TTM Q/Q Growth Statistics
High Average Low
2201.58 %
108.63 %
-111.89 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 52
Healthcare Sector # 38
Overall # 109

Revenue TTM Y/Y Growth Statistics
High Average Low
2201.58 %
108.63 %
-111.89 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 52
Sector # 109
S&P 500 # 391
Cumulative Revenue growth Comment
Zogenix Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 830.31% year on year, to $ 82 millions if the fiscal year would have ended in Dec 31 2021.
Zogenix Inc 's trailing twelve months Revenue growth was higher than company's average 108.63% and higher than % growth in Sep 30 2021.
But from the previous reporting period increase was slower at 40.98 % from $57.94 millions recorded in twelve months ending a quarter before Jacob  Taylor went on.
It appears to be slowdown happening, more noticeable observing the typical sequential historic advancement which is higher at 108.63% Jacob  Taylor published.
The momentum was much higher from the previous reporting period showed at 40.98 % jump from $57.94 millions in the period from Sep 30 2021 to Sep 30 2020. In the Dec 31 2021 period, Zogenix Inc had cumulative twelve months Revenue of $ 82 millions compare to of $ -2 millions a year ago.
Singns of recovery, but very slow one, reporting beneth usual 40.98 % Revenue rise, from $57.94 millions from the twelve months ending in the quarter before Jacob  Taylor mentioned.

In the Healthcare sector 37 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 109.

Revenue TTM Q/Q Growth Statistics
High Average Low
2201.58 %
108.63 %
-111.89 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 52
Healthcare Sector # 38
Overall # 109

Revenue TTM Y/Y Growth Statistics
High Average Low
2201.58 %
108.63 %
-111.89 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 52
Sector # 109
S&P 500 # 391




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ZGNX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ZGNX's Competitors
Revenue Growth for Zogenix Inc 's Suppliers
Revenue Growth for ZGNX's Customers

You may also want to know
ZGNX's Annual Growth Rates ZGNX's Profitability Ratios ZGNX's Asset Turnover Ratio ZGNX's Dividend Growth
ZGNX's Roe ZGNX's Valuation Ratios ZGNX's Financial Strength Ratios ZGNX's Dividend Payout Ratio
ZGNX's Roa ZGNX's Inventory Turnover Ratio ZGNX's Growth Rates ZGNX's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Dec 31 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2021
Kazia Therapeutics Limited1,426.13%$ 1,426.131 millions
Inmune Bio Inc 1,393.22%$ 1,393.221 millions
Guardion Health Sciences Inc 1,213.59%$ 1,213.587 millions
Moderna Inc 1,163.44%$ 1,163.436 millions
Albireo Pharma inc 1,097.39%$ 1,097.386 millions
Option Care Health Inc 1,023.60%$ 1,023.599 millions
Genfit S a 1,003.11%$ 1,003.106 millions
Ethema Health Corporation 967.17%$ 967.166 millions
Dynavax Technologies Corporation897.80%$ 897.801 millions
Inspiremd Inc 789.87%$ 789.873 millions
Prophase Labs Inc 774.63%$ 774.627 millions
Cytokinetics Incorporated727.13%$ 727.135 millions
Theralink Technologies Inc 706.69%$ 706.691 millions
Beyondspring Inc 650.56%$ 650.556 millions
Meiragtx Holdings Plc504.51%$ 504.513 millions
Guided Therapeutics Inc 492.00%$ 492.000 millions
Lftd Partners Inc 482.17%$ 482.175 millions
Cardiff Lexington Corporation465.13%$ 465.127 millions
Lumos Pharma Inc 450.00%$ 450.000 millions
Baudax Bio Inc 426.32%$ 426.316 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com